Integrum AB Series B (INTEG-B) - Total Liabilities

Latest as of September 2025: Skr22.09 Million SEK ≈ $2.38 Million USD

Based on the latest financial reports, Integrum AB Series B (INTEG-B) has total liabilities worth Skr22.09 Million SEK (≈ $2.38 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Integrum AB Series B (INTEG-B) cash conversion ratio to assess how effectively this company generates cash.

Integrum AB Series B - Total Liabilities Trend (2013–2024)

This chart illustrates how Integrum AB Series B's total liabilities have evolved over time, based on quarterly financial data. See Integrum AB Series B (INTEG-B) net assets for net asset value and shareholders' equity analysis.

Integrum AB Series B Competitors by Total Liabilities

The table below lists competitors of Integrum AB Series B ranked by their total liabilities.

Company	Country	Total Liabilities
Patagonia Lithium Ltd AU:PL3	Australia	AU$187.38K
UTStarcom Holdings Corp NASDAQ:UTSI	USA	$20.69 Million
Sikko Industries Limited NSE:SIKKO	India	Rs493.72 Million
K-One Technology Bhd KLSE:0111	Malaysia	RM86.47 Million
Bluglass Ltd AU:BLG	Australia	AU$9.69 Million
Alpha Group International plc LSE:ALPH	UK	GBX294.65 Million
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares NASDAQ:ZJYL	USA	$23.80 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Integrum AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Integrum AB Series B (INTEG-B) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.44	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Integrum AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Integrum AB Series B (2013–2024)

The table below shows the annual total liabilities of Integrum AB Series B from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr25.38 Million ≈ $2.73 Million	+14.98%
2023-12-31	Skr22.07 Million ≈ $2.38 Million	+2.01%
2022-12-31	Skr21.64 Million ≈ $2.33 Million	+4.55%
2021-12-31	Skr20.70 Million ≈ $2.23 Million	+60.25%
2020-12-31	Skr12.91 Million ≈ $1.39 Million	+52.49%
2019-12-31	Skr8.47 Million ≈ $911.38K	-4.33%
2018-12-31	Skr8.85 Million ≈ $952.60K	+5.65%
2017-12-31	Skr8.38 Million ≈ $901.62K	-9.31%
2016-12-31	Skr9.24 Million ≈ $994.23K	+2.27%
2015-12-31	Skr9.03 Million ≈ $972.20K	+71.03%
2014-12-31	Skr5.28 Million ≈ $568.43K	-5.99%
2013-12-31	Skr5.62 Million ≈ $604.66K	--

About Integrum AB Series B

ST:INTEG-B Sweden Medical Devices

Market Cap

$21.96 Million

Skr204.06 Million SEK

Market Cap Rank

#24741 Global

#499 in Sweden

Share Price

Skr7.84

Change (1 day)

-1.63%

52-Week Range

Skr6.96 - Skr43.10

All Time High

Skr102.00